LABCORP HOLDINGS INC. LH

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $317.94
Market Cap $26.46B
P/E Ratio 30.40
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑7.2% YoY
$13.95B
3-Yr CAGR: 5.6%
Net Income ↑17.5% YoY
$876.50M
Net Margin: 6.3%
Free Cash Flow ↑10.0% YoY
$1.21B
FCF Yield: 4.56%
EPS (Diluted) ↑18.3% YoY
$10.46
Basic: $10.54
Return on Equity Efficiency
10.2%
ROA: 126.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (LH)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $9,437.2M $3,180.5M $732.1M $7.02 $1,175.9M $897.0M
FY 2017 $10,205.9M +8.1% $3,464.0M $1,268.2M +73.2% $12.21 +73.9% $1,459.4M $1,146.5M +27.8%
FY 2018 $11,333.4M +11.0% $3,176.4M $883.7M -30.3% $8.61 -29.5% $1,305.4M $925.6M -19.3%
FY 2019 $11,554.8M +2.0% $3,252.5M $823.8M -6.8% $8.35 -3.0% $1,444.7M $1,044.5M +12.8%
FY 2020 $13,978.5M +21.0% $4,952.8M $1,556.1M +88.9% $15.88 +90.2% $2,135.3M $1,753.6M +67.9%
FY 2021 $16,120.9M +15.3% $5,624.3M $2,377.3M +52.8% $24.39 +53.6% $3,109.6M $2,649.2M +51.1%
FY 2022 $11,863.9M -26.4% $3,708.9M $1,279.1M -46.2% $13.97 -42.7% $1,955.9M $1,526.6M -42.4%
FY 2023 $12,161.6M +2.5% $3,364.9M $418.0M -67.3% $4.77 -65.9% $1,327.7M $874.1M -42.7%
FY 2024 $13,008.9M +7.0% $3,624.4M $746.0M +78.5% $8.84 +85.3% $1,585.8M $1,095.9M +25.4%
FY 2025 $13,951.7M +7.2% $4,012.5M $876.5M +17.5% $10.46 +18.3% $1,640.5M $1,206.0M +10.0%
$

Valuation

Market Price $317.94
Market Cap $26.46B
Enterprise Value $31.51B
P/E Ratio 30.40
P/B Ratio 3.02
FCF Yield 4.56%
Dividend Yield N/A
Shares Outstanding 82,000,000
%

Profitability & Margins

Gross Margin 28.76%
Operating Margin 9.92%
Net Margin 6.28%
Return on Equity (ROE) 10.17%
Return on Assets (ROA) 126.52%
Asset Turnover 20.14x
Revenue 3-Yr CAGR 5.55%
🛡️

Financial Health & Liquidity

Current Ratio 0.82
Cash Ratio 0.63
Debt / Equity 0.648
Debt / Assets 8.061
Cash & Equivalents $532.30M
Total Debt $5.58B
Book Value / Share $105.12
💧

Cash Flow Efficiency

Operating Cash Flow $1.64B
Capital Expenditures (CapEx) $434.50M
Free Cash Flow $1.21B
OCF / Revenue 11.76%
FCF / Revenue 8.64%
FCF 3-Yr CAGR -7.56%
🏷️

Per Share Metrics

EPS (Diluted) $10.46
EPS (Basic) $10.54
Dividends / Share N/A
Book Value / Share $105.12
EPS YoY Growth 18.33%
🏛️

Balance Sheet (FY 2025)

Total Assets $692.80M
Total Liabilities $847.80M
Stockholders' Equity $8.62B
Current Assets $692.80M
Current Liabilities $847.80M